Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era: The GISSI-2 results

Circulation

Volumn 94, Issue 3, 1996, Pages 432-436

  Zuanetti, Giulio ^b,c   Neilson, James M M ^a   Latini, Roberto ^b   Santoro, Eugenio ^b   Maggioni, Aldo P ^b   Ewing, David J ^a  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b GISSI Coordinating Centre   (Italy)

^c MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

electrocardiography; fibrinolysis; heart rate; myocardial infarction; prognosis

Indexed keywords

ALTEPLASE; DIGITALIS; HEPARIN; STREPTOKINASE;

AGED; AGING; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; DOSE RESPONSE; FEMALE; FIBRINOLYSIS; HEART DEATH; HEART INFARCTION; HEART RATE; HIGH RISK PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0029790652     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.3.432     Document Type: Article

References (16)

1. Kleiger RE, Miller JP, Bigger JT, Moss AJ, and the Multicenter Post-Infarction Research Group. Decreased heart rate variability and its association with increased mortality after acute myocardial infarction. Am J Cardiol. 1987;59:256-262.
2. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Frequency domain measures of heart period variability and mortality after myocardial infarction. Circulation. 1992;85:164-171.
3. Bigger JT, Fleiss JL, Steinman RC, Rolnitzky LM, Kleiger RE, Rottman JN. Correlations among time and frequency domain measures of heart period variability two weeks after acute myocardial infarction. Am J Cardiol. 1992;69:891-898.
4. Kleiger RE, Miller JP, Bigger JT, Rolnitzky LM, and the Multicenter Diltiazem Postinfarction Trial (MDPIT) Research Group. Cycle length variability predicts cardiac mortality independent of diltiazem therapy. J Am Coll Cardiol. 1990;15:190A. Abstract.
5. Farrell TG, Bashir Y, Cripps T, Malik M, Poloniecki J, Bennett ED, Ward DE, Camm AJ. Risk stratification for arrhythmic events in post-infarction patients based on heart rate variability, ambulatory etectrocardiographic variables and the signal-averaged electrocardiogram. J Am Coll Cardiol. 1991;18:687-697.
6. Maggioni AP, Zuanetti G, Franzosi MG, Rovelli F, Santoro E, Staszewsky L, Tavazzi L, Tognoni G. Prevalence and prognostic significance of ventricular arrhythmias after acute myocardial infarction in the fibrinolytic era: GISSI-2 results. Circulation. 1993;87:312-322.
7. Volpi A, De Vita C, Franzosi MG, Geraci E, Maggioni AP, Mauri F, Negri E, Santoro E, Tavazzi L, Tognoni G. Determinants of 6-month mortality in survivors of myocardial infarction after throm bolysis: results of the GISSI-2 data base. Circulation. 1993;88:416-429.
8. GISSI-2 Investigators. GISSI-2: a factorial randomised trial of alteplase versus streptokinase and heparin versus no heparin among 12,490 patients with acute myocardial infarction. Lancet. 1990; 336:65-71.
9. Ewing DJ, Neilson JMM, Travis P. New method for assessing cardiac parasympathetic activity using 24 hour electrocardiograms. Br Heart J. 1984;52:396-402.
10. Neilson JM. High speed analysis of ventricular arrhythmias from 24 hour recordings. Comput Cardiol. 1974;55-61.
11. Schwartz PJ, Priori SG. Sympathetic nervous system and cardiac arrhythmias. In: Zipes DP, Jalife J, eds. Cardiac Electrophysiology: From Cell to Bedside. Philadelphia, Pa: WB Saunders Co; 1990:330-342.
12. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation. 1991; 84:482-492.
13. Myers GA, Martin GJ, Magid NM, Barnett PS, Shaad JW, Weiss JS, Lesch M, Singer DH. Power spectral analysis of heart rate variability in sudden cardiac death: comparison to other methods. IEEE. 1986; BME-33:1149-1156.
14. The GUSTO Investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 1993;329:673-682.
15. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto Miocardico. GISSI-3: effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Lancet. 1994;343:1115-1122.
16. American College of Cardiology Cardiovascular Technology Assessment Committee. Heart rate variability of risk stratification of life-threatening arrhythmias. J Am Coll Cardiol. 1993;22:948-950.